The transaction closure is anticipated in early 2026, contingent on regulatory approvals and other customary conditions.
Background. Reliable reverse transcription polymerase chain reaction (RT-PCR)–based diagnosis of Ebola virus infection currently requires a blood sample obtained by intravenous puncture. During the ...
Hims & Hers Health (HIMS) has entered into an agreement to acquire YourBio Health, a Boston-based maker of capillary whole ...